Th1/Th2/Th17/Treg expression in cultured PBMCs with antiphospholipid antibodies

Molecular Medicine Reports

Volumn 6, Issue 5, 2012, Pages 1035-1039

  Xiao, Jing ^a   Zhu, Fufan ^a   Liu, Xinli ^a   Xiong, Jing ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Antiphospholipid antibodies; Regulatory T cell; T helper cell subtypes Th1 Th2 Th17; Titers

Indexed keywords

CARDIOLIPIN ANTIBODY; PHOSPHOLIPID ANTIBODY;

ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; UPREGULATION;

ANTIBODIES, ANTIPHOSPHOLIPID; CELL DIFFERENTIATION; CELLS, CULTURED; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS; TH2 CELLS;

EID: 84866457717     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.1055     Document Type: Article

References (34)

1. Miyakis S, Lockshin MD, Atsumi T, et al : International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4: 295-306, 2006.
2. Silver RM, Porter TF, van Leeuween I, Jeng G, Scott JR and Branch DW: Anticardiolipin antibodies: clinical consequences of 'low titers'. Obstet Gynecol 87: 494-500, 1996.
3. Levine SR, Salowich-Palm L, Sawaya KL, et al: IgG anticardiolipin antibody titer > 40 GPL and the risk of subse quent thrombo-occlusive events and death. A prospective cohort study. Stroke 28: 1660-1665, 1997. (Pubitemid 27391430)
4. Erkan D, Barbhaiya M, George D, Sammaritano L and Lockshin M: Moderate versus high-titer persistently anticardiolipin antibody positive patients: are they clinically different and does high-titer anti-beta 2-glycoprotein-I antibody positivity offer additional predictive information? Lupus 19: 613-619, 2010.
5. Tuhrim S, Rand JH, Wu XX, et al: Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity. Stroke 30: 1561-1565, 1999. (Pubitemid 29379603)
6. Bakimer R, Fishman P, Blank M, Sredni B, Djaldetti M and Shoenfeld Y: Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest 89: 1558-1563, 1992.
7. Pierangeli SS and Harris EN: Induction of phospholipid-binding antibodies in mice and rabbits by immunization with human beta 2 glycoprotein 1 or anticardiolipin antibodies alone. Clin Exp Immunol 93: 269-272, 1993. (Pubitemid 23238039)
8. Krause I, Blank M, Levi Y, Koike T, Barak V and Shoenfeld Y: Anti-idiotype immunomodulation of experimental anti-phospholipid syndrome via effect on Th1/Th2 expression. Clin Exp Immunol 117: 190-197, 1999. (Pubitemid 29292797)
9. Fischer K, Collins H, Taniguchi M, Kaufmann SH and Schaible UE: IL-4 and T cells are required for the generation of IgG1 isotype antibodies against cardiolipin. J Immunol 168: 2689-2694, 2002. (Pubitemid 34211645)
10. Soltesz P, Der H, Veres K, et al: Immunological features of primary anti-phospholipid syndrome in connection with endothelial dysfunction. Rheumatology (Oxford) 47: 1628-1634, 2008.
11. Karakantza M, Theodorou GL, Meimaris N, et al: Type 1 and type 2 cytokine-producing CD4+ and CD8+ T cells in primary antiphospholipid syndrome. Ann Hematol 83: 704-711, 2004. (Pubitemid 39440215)
12. Amital H, Gilburd B and Shoenfeld Y: Probiotic supplementation with Lactobacillus casei (Actimel) induces a Th1 response in an animal model of antiphospholipid syndrome. Ann N Y Acad Sci 1110: 661-669, 2007. (Pubitemid 350043055)
13. Visvanathan S and McNeil HP: Cellular immunity to beta 2-glycoprotein-1 in patients with the antiphospholipid syndrome. J Immunol 162: 6919-6925, 1999. (Pubitemid 29309421)
14. Fu J, Fy Q and Si CP: Changes of CD4+CD25+ regulatory T cells and foxp3 expression in rats with experimental anti-phospholipid antibody syndrome. Matern Child Healthcare Chin 25: 821-824, 2010.
15. Lin H, Mosmann TR, Guilbert L, Tuntipopipat S and Wegmann TG: Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 151: 4562-4573, 1993. (Pubitemid 23318510)
16. Marzi M, Vigano A, Trabattoni D, et al: Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 106: 127-133, 1996. (Pubitemid 26329391)
17. Sugiura-Ogasawara M, Furukawa TA, Nakano Y, Hori S, Aoki K and Kitamura T: Depression as a potential causal factor in subsequent miscarriage in recurrent spontaneous aborters. Hum Reprod 17: 2580-2584, 2002. (Pubitemid 35174107)
18. Yokoo T, Takakuwa K, Ooki I, Kikuchi A, Tamura M and Tanaka K: Alteration of TH1 and TH2 cells by intracellular cytokine detection in patients with unexplained recurrent abortion before and after immunotherapy with the husband's mononuclear cells. Fertil Steril 85: 1452-1458, 2006.
19. Bonelli M, Savitskaya A, von Dalwigk K, et al: Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Int Immunol 20: 861-868, 2008. (Pubitemid 351876312)
20. Behrens F, Himsel A, Rehart S, et al: Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis. Ann Rheum Dis 66: 1151-1156, 2007. (Pubitemid 47309729)
21. Li X, Qian L, Wang G, et al: T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjogren's syndrome. J Rheumatol 34: 2438-2445, 2007. (Pubitemid 350230668)
22. Dalla Libera D, Di Mitri D, Bergami A, et al: T regulatory cells are markers of disease activity in multiple sclerosis patients. PLoS One 6: e21386, 2011.
23. Miyara M, Gorochov G, Ehrenstein M, Musset L, Sakaguchi S and Amoura Z: Human FoxP3+ regulatory T cells in systemic autoimmune diseases. Autoimmun Rev 10: 744-755, 2011.
24. Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A and Saito S: Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 10: 347-353, 2004. (Pubitemid 38714366)
25. Fraccaroli L, Alfieri J, Larocca L, et al : A potential tolerogenic immune mechanism in a trophoblast cell line through the activation of chemokine-induced T cell death and regulatory T cell modulation. Hum Reprod 24: 166-175, 2009.
26. Arruvito L, Sotelo AI, Billordo A and Fainboim L: A physiological role for inducible FOXP3(+) Treg cells. Lessons from women with reproductive failure. Clin Immunol 136: 432-441, 2010.
27. McKenzie BS, Kastelein RA and Cua DJ: Understanding the IL-23-IL-17 immune pathway. Trends Immunol 27: 17-23, 2006. (Pubitemid 43083560)
28. Steinman L: A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13: 139-145, 2007.
29. Wang WJ, Hao CF, Qu QL, Wang X, Qiu LH and Lin QD: The deregulation of regulatory T cells on interleukin-17-producing T helper cells in patients with unexplained early recurrent miscarriage. Hum Reprod 25: 2591-2596, 2010.
30. Liu YS, Wu L, Tong XH, et al: Study on the relationship between Th17 cells and unexplained recurrent spontaneous abortion. Am J Reprod Immunol 65: 503-511, 2011.
31. Nakashima A, Ito M, Shima T, Bac ND, Hidaka T and Saito S: Accumulation of IL-17-positive cells in decidua of inevitable abortion cases. Am J Reprod Immunol 64: 4-11, 2010.
32. Ogura H, Murakami M, Okuyama Y, et al: Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity 29: 628-636, 2008.
33. Ferrara DE, Swerlick R, Casper K, et al: Fluvastatin inhibits up-regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells. J Thromb Haemost 2: 1558-1563, 2004. (Pubitemid 40186171)
34. Mulla MJ, Brosens JJ, Chamley LW, et al: Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway. Am J Reprod Immunol 62: 96-111, 2009.